Capricor Therapeutics, Inc.
CAPR
$31.17
$0.270.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -323.95% | -95.68% | -135.56% | -149.04% | -833.81% |
| Total Depreciation and Amortization | 33.78% | 36.96% | 36.26% | 22.36% | 22.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.44% | 114.73% | 69.43% | 80.42% | 29.17% |
| Change in Net Operating Assets | 88.92% | 100.38% | 144.14% | 136.48% | 19.58% |
| Cash from Operations | -59.27% | -69.11% | -63.75% | -407.21% | -27.62% |
| Capital Expenditure | -597.54% | -6,695.59% | -1,691.97% | -71.65% | -0.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 139.31% | 867.21% | 8.28% | 383.23% | -2,289.19% |
| Cash from Investing | 134.92% | 695.72% | -0.99% | 351.43% | -2,004.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 206.85% | -99.99% | -99.05% | -97.80% | 250.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 206.85% | -99.99% | -99.05% | -97.80% | 250.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 570.02% | -106.47% | -224.13% | 306.45% | -1,099.80% |